CONFERENCES

    Annual Nicotine and Tobacco Science Conference

    The Nicotine and Tobacco Science Conference (NTSC) is aimed at "across the aisle" discussion, bringing leading academic and industry researchers together with a focus on smoking cessation, tobacco harm reduction, and understanding the underlying mechanisms contributing to cigarette addiction. NTSC welcomes academic and clinical scientists, health care practitioners, global public health, and members of the pharmaceutical, nicotine, and tobacco industries.

    Nicotine and Tobacco Science Conference 2024

    Date

    Oct 28, 2024 - Oct 29, 2024

    Location

    Charleston, U.S.

    Online

    The 27th Nicotine and Tobacco Science Conference, hosted by the Medical University of South Carolina, focuses on "Risks and Benefits of Consumer Nicotine Delivery Systems: Emerging Evidence and Open Questions." 

    See related posters

    Nicotine and Tobacco Science Conference 2023

    Date

    Oct 19, 2023

    Location

    Durham, USA

    The 26th Annual Nicotine and Tobacco Science Conference features industry leading speakers to help us dive deep into discussion on smoking cessation and tobacco harm reduction.

    PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts in support of its smoke-free product portfolio. This site is a global site for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not advertising or marketing, nor is it directed at any specific market. It is not intended for use by consumers. New tobacco products sold in the United States are subject to FDA regulation; therefore the content of this site is not intended to make, and nor should it be construed as making, any product related claims in the United States without proper FDA authorization. ​
    ​
    Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. All of our RRPs are smoke-free products that deliver nicotine with far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.